REVVITY OMICS

Trademark usage description

performance of chemical or biological material analysis or diagnostics, namely, detection and screening for biological or chemical substances, capilla Read More

Classification Information

Class [042]
Performance of chemical or biological material analysis or diagnostics, namely, detection and screening for biological or chemical substances, capillary electrophoresis, chemical or biological separation, and nucleic characterization; medical laboratories; medical research; providing scientific information about products and services in the fields of human health technology; scientific research and development services, namely, collecting information and user comments about the scientific and technological qualities of products and services in the fields of human health technology; medical diagnostic software and medical testing software for medical laboratory data management, patient record keeping, tracking, recording, monitoring, analyzing and reporting medical data obtained related to newborn screenings; establishing patient genotypes for research or analysis purposes; disease modelling for research purposes.

Classification kind code

Class [044]
Medical diagnostic testing services; medical diagnostic testing services, namely, testing for tick-borne infections; medical analysis services for diagnostic and monitoring purposes provided by medical laboratories; medical and health services relating to DNA, genetics and genetic testing; genetic testing for medical purposes; DNA screening for medical purposes; medical services.

Classification kind code

Mark Details

Serial Number

2312887

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 256 on 31^st Dec 2024	Notification of Possible Opposition Sent
Submitted for opposition 257 on 29^th Feb 2024	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 28^th Feb 2024	Created
Submitted for opposition 31 on 28^th Feb 2024	Formalized
Submitted for opposition 30 on 22^nd Dec 2023	Filed
Submitted for opposition 228 on 22^nd Dec 2023	International Registration